Searchable abstracts of presentations at key conferences in endocrinology

ea0055p36 | Poster Presentations | SFEEU2018

Severe necrotising pancreatitis secondary to hypertriglyceridaemia in pregnancy

Graham Julia , Gunganah Kirun , Williams David , Lunken Catherine , Srirangalingam Umasuthan

Case history: A 35-year-old woman with known hypertriglyceridaemia presented with a one day history of abdominal pain, vomiting and fever. She was 14 weeks pregnant having conceived spontaneously following a period of infertility. She had discontinued her lipid-lowering medication and was managed with diet alone. On examination, she was pyrexial, tachycardic (HR=100 bpm), normotensive (BP=111/71 mmHg), oxygen saturation was 96% on air and she had a tender distended abdomen. A ...

ea0099ep450 | Pituitary and Neuroendocrinology | ECE2024

Routine monitoring for acromegaly-associated complications and recurrence: a single-centre audit

Nawaz Asif , Williams David , Guy Fiona , Min Thinzar , Yin Win

Introduction: Endocrine society guidelines advocate early colonoscopy and monitoring for acromegaly-associated complications and recurrence. We aimed to establish whether people with acromegaly under our care received appropriate monitoring.Methods: Patients under follow-up with acromegaly diagnosed 1989-2021 were included. Electronic health records were accessed for clinic letters, colonoscopy reports, blood and imaging results from the diagnosis to rec...

ea0099ep451 | Thyroid | ECE2024

Thyroxine intolerance: a rare but significant clinical entity

Nawaz Asif , Williams David , Taylor Peter , Min Thinzar , Yin Win

Introduction: Levothyroxine, the standard therapy for hypothyroidism, is usually well tolerated and very few cases of true allergy to levothyroxine have been reported to date. Here we report two cases of rare occurrence of levothyroxine allergy.Case 1: A 56-year-old woman with no previous history of allergies started levothyroxine post-thyroidectomy for Graves’ disease. She developed facial flushing and urticarial rash within 15 minutes of the first...

ea0086p306 | Adrenal and Cardiovascular | SFEBES2022

Appropriateness of aldosterone renin ratio (ARR) testing: A retrospective multicentre audit

Williams David M , Shaikh Ayesha , Williams Ellen , Maroof Aiman , Michael Therese , Boregowda Kusuma

Introduction: Clinical practice guidelines advocate testing the aldosterone-renin ratio (ARR) in specific circumstances only. Tests should be taken following abstinence from drugs associated with false results. We aimed to determine the appropriateness of testing locally and any associated wasted healthcare costs.Methods: We retrospectively evaluated ARR requests taken July-October 2019 and July-October 2021 in Swansea Bay University Health Board to dete...

ea0090p501 | Thyroid | ECE2023

An unremarkable presentation but signs of Grave danger: Never forget the thyroid function

Essame Jenna , M Williams David , Shaikh Ayesha , Atkinson Michael , Udiawar Maneesh , Boregowda Kusuma

Introduction: Profound thyrotoxicosis commonly presents with heat intolerance, sweating, weight loss, palpitations, tremor, goitre and eye signs in the case of Grave’s disease. Typically, thyroid storm is differentiated by marked volume depletion, congestive cardiac failure, cardiac arrhythmias, confusion, nausea and vomiting, often with extreme agitation. The wide-ranging and systemic manifestations associated with profound hyperthyroidism are mediated through the thyroi...

ea0070oc4.7 | Pituitary and Neuroendocrinology | ECE2020

Fluid restriction results in a modest rise in plasma sodium concentration in chronic hyponatraemia due to SIAD; results of a prospective randomised controlled trial

Garrahy Aoife , Galloway Iona , Hannon Anne Marie , Dineen Rosemary , O’Kelly Patrick , Tormey William , O’Reilly Michael , Williams David , Sherlock Mark , Thompson Chris

Fluid restriction (FR) is the recommended first-line treatment for chronic hyponatraemia due to syndrome of inappropriate antidiuresis (SIAD) in expert guidelines, despite the lack of prospective data to support its efficacy. We aimed to test the hypothesis that FR was more effective than no treatment. 46 patients with chronic SIAD were randomised to either fluid restriction (1 litre/day, FR) or no specific hyponatraemia treatment (NoTx) for one month. Inclusion criteria were ...